Skip to main content
. 2022 Feb 22;6(2):e22.00009. doi: 10.5435/JAAOSGlobal-D-22-00009

Table 2.

Comparison of Surgical Data and Long-Term Survival for the Appendicular and Axial Cohorts

Patient Characteristic Total Appendicular Axial Other P
No. of patients 4,430 3,435 810 185
Surgical treatment <0.001
 No surgery 755 (17.04) 470 (13.68) 225 (27.78) 60 (32.43)
 Surgery 3,669 (82.82) 2,959 (86.14) 585 (72.22) 125 (67.57)
 Unknown 6 (0.14) 6 (0.17) 0 (0.00) 0 (0.00)
Radiation therapy <0.001
 None 4,147 (93.61) 3,321 (96.69) 667 (82.35) 159 (85.95)
 Preoperative 31 (0.70) 14 (0.41) 13 (1.60) 4 (2.16)
 Postoperative 182 (4.11) 454 (1.57) 110 (13.58) 18 (9.73)
 Both or intraoperative 8 (0.18) 4 (0.12) 4 (0.49) 0 (0.00)
 Unknown 62 (1.40) 42 (1.22) 16 (1.98) 4 (2.16)
Chemotherapy <0.001
 No (0) 862 (19.46) 542 (15.78) 261 (32.22) 59 (31.89)
 Yes (1) 3,500 (79.01) 2,851 (83.00) 525 (64.81) 124 (67.03)
 Unknown (2) 68 (1.53) 42 (1.22) 24 (2.96) 2 (1.08)
Treatment combination <0.001
 No treatment 274 (6.19) 152 (4.43) 96 (11.85) 26 (14.05)
 Isolated surgery 625 (14.11) 445 (12.95) 157 (19.38) 23 (12.43)
 Isolated radiation 6 (0.14) 1 (0.03) 3 (0.37) 2 (1.08)
 Isolated chemotherapy 570 (12.87) 381 (11.09) 152 (18.77) 37 (20.00)
 Surgery and radiation 69 (1.56) 16 (0.47) 40 (4.94) 13 (7.03)
 Surgery and chemotherapy 2,741 (61.87) 2,385 (69.43) 280 (34.57) 76 (41.08)
 Chemotherapy and radiation 2 (0.05) 1 (0.03) 1 (0.12) 0 (0.00)
 Surgery, radiation, and chemotherapy 143 (3.23) 54 (1.57) 81 (10.00) 8 (4.32)
Survival <0.001
 1-yr survival (%) 87.1 91.17 74.22 67.33
 5-yr survival (%) 60.17 64.43 45.97 42.57
 10-yr survival (%) 53.92 58.58 38.27 NA

No statistically significant difference exists between the era groups for the above variables, within the appendicular or axial cohorts.

Significance set at <0.05.